To determine the role of CD169+ macrophages in brain tumors, diphtheria toxin (DT) was administered to mice expressing the diphtheria toxin receptor in CD169+ cells (CD169-DTR). This evidence concerns the gene SIGLEC1 and brain neoplasm.